Latest News

US approves second COVID-19 vaccine Moderna for emergency use

The U.S. Food and Drug Administration has authorized American drugmaker Moderna’s COVID-19 vaccine for emergency use in the United States of America.

Moderna becomes the second COVID-19 vaccine to receive FDA emergency use authorization. The FDA Had approved Pfizer-BioNTech’s vaccine for emergency use earlier this month.

The vaccine, from U.S. drugmaker Moderna, was developed with the National Institutes of Health.

Earlier on Friday,  U.S. Vice President Mike Pence and U.S. House Speaker Nancy Pelosi received their first COVID-19 vaccinations.

Vice President Mike Pence receives a Pfizer-BioNTech COVID-19 vaccine shot at the Eisenhower Executive Office Building on the…
Vice President Mike Pence receives a Pfizer-BioNTech COVID-19 vaccine shot at the Eisenhower Executive Office Building on the White House complex, Dec. 18, 2020, in Washington.
Speaker of the House Nancy Pelosi, D-Calif., receives a Pfizer-BioNTech COVID-19 vaccine shot by Dr. Brian Monahan, attending…
 
Speaker of the House Nancy Pelosi, D-Calif., receives a Pfizer-BioNTech COVID-19 vaccine shot by Dr. Brian Monahan, attending physician Congress of the United States, in Washington, Dec. 18, 2020.

The two vaccines work “better than we almost dared to hope,” National Institutes of Health Director Dr. Francis Collins said. “Science is working here; science has done something amazing.”

After the approval, the U.S. drugmaker will begin transporting millions of doses for health workers and nursing home residents, and it could arrive Monday.

Saman Siddiqui

I am a freelance journalist, holding a Master’s Degree in Mass Communication and an MS in Peace and Conflict Studies, associated with the electronic media industry since 2006 in various capacities. Here at OyeYeah, I cover a range of genres, from journalism to fiction to fashion, including reviews, and fact findings. 

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button